Evidence review
GLP-1 Before Surgery: What to Ask Your Anesthesia Team
Plan GLP-1 medication around surgery or sedation with your anesthesia team. Understand risk review, conflicting instructions and the restart conversation.
Tell your surgeon and anesthesia team that you take a GLP-1 medicine well before a procedure. Many patients can continue treatment under multisociety guidance, but the plan depends on aspiration risk, symptoms, dose changes and the procedure. Do not independently stop or continue treatment based on a universal online rule.
This matters for procedures involving general anesthesia or deep sedation, which can include some endoscopies and other outpatient care. Your prescribing clinician, proceduralist and anesthesia team may work in different offices. Make sure each has the same medication history and that you receive one clear plan.
Why does the anesthesia team need to know?
GLP-1 medicines can delay stomach emptying. Residual stomach contents can create an aspiration concern during anesthesia or deep sedation. Current U.S. prescribing information for Wegovy and Zepbound includes warnings about this issue and asks patients to inform clinicians before planned procedures.1,2
The point is not that everyone taking a GLP-1 must cancel a procedure. It is that the anesthesia team needs relevant information to assess risk and plan care. A routine medication list that omits a weight-loss injection or tablet can leave that team without a detail that matters.
Include the exact medicine, route and schedule, even if you buy it through a separate telehealth program. If it is compounded, say so and provide the prescription label. Do not assume the surgeon can see the online company's records or that a preoperative questionnaire automatically reaches your GLP-1 prescriber.
What does multisociety guidance say?
The 2024 multisociety guidance described by the American Society of Anesthesiologists supports continuing GLP-1 treatment for many patients. It calls for individualized review, with greater attention to factors such as dose escalation, significant gastrointestinal symptoms and other conditions affecting stomach emptying. The team may use a liquid-only diet before the procedure, alter the anesthesia plan, assess stomach contents or delay a procedure when appropriate.3
That is a risk-based approach, rather than an instruction for every patient to use one pause interval. The team also weighs the consequences of withholding treatment, including effects on blood sugar in people with diabetes. The guidance's date matters: older instructions can describe a different approach.3
The summary does not set your individual fasting, medication or diet instructions. Follow the team responsible for your procedure and ask them to resolve uncertainty. If an office sends a generic instruction sheet, tell it about your exact medicine and ask whether the sheet reflects your assessed plan.
What information should you bring to the preoperative review?
Make a concise list with the prescribing clinician's contact information. It is easier for the team to clarify the plan when the relevant dose and dates are available. Provide the same list to the procedural office and your online care team.
| Information | What to include |
|---|---|
| Exact medicine | Brand or compounded product, route and device |
| Current prescription | Dose and frequency |
| Recent changes | Start date and the most recent increase |
| Actual doses | Date of the last dose taken |
| Digestive symptoms | Nausea, vomiting, abdominal discomfort, constipation or other concerns |
| Other conditions and medicines | The full history requested by the team |
| Procedure details | Planned date, type and expected anesthesia or sedation |
Describe symptoms plainly rather than deciding yourself whether they count as severe enough to mention. If they changed after the last dose increase, give that timeline. The team needs the facts, and it decides how those facts affect the procedure.
Should you hold the medicine for a week?
Do not assume that a weekly medicine always requires a one-week pause. Different guidance and institutional procedures may use different approaches. Your team's plan should reflect your medication, clinical situation and planned procedure. A family member's instructions do not establish yours.
If the surgeon says to stop but the prescriber says to continue, ask the offices to communicate before the next dose decision. Explain the conflict with the written messages or instructions attached. Avoid choosing between them on your own or silently withholding information from one team.
If there is little time before the procedure, contact the procedural team directly and state when you last took the medicine. Do not assume the procedure must be canceled, and do not assume it is safe to proceed unchanged. The anesthesia team needs that information to make the decision.
Is a liquid diet the same as routine fasting?
No. A plan involving a preprocedure liquid-only diet and the instructions about when to stop eating or drinking are separate parts of preparation. Ask the procedural team exactly what each instruction means for you, including what liquids are allowed and when the relevant periods begin and end.
Do not create your own liquid diet based on a social media list. Diabetes medicines, glucose management and other conditions may need coordinated instructions. Ask who to call if you cannot follow the preparation, develop symptoms or accidentally eat or drink outside the plan.
Write down the instructions in a format you can use: what to do the day before, what to do on the procedure day and whom to contact. If the team updates the plan, replace the older copy so you do not follow two incompatible versions.
What if you take a GLP-1 for diabetes?
Tell the team the indication and list all glucose-lowering medicines. If a pause is planned, ask the prescribing clinician about glucose monitoring and the rest of your regimen. Do not independently substitute an extra dose of another medicine or skip insulin because your GLP-1 schedule changes.
The clinical question includes the effect of interrupted treatment as well as the procedural risk. This is why the anesthesia and prescribing teams should coordinate. A provider comparison article cannot set that balance for an individual patient.
Ask which team is responsible for questions before the procedure and after discharge. If the surgeon's office directs you back to the prescriber, give the prescriber the procedural instructions so the reply addresses the actual plan.
What should you do for an urgent procedure?
Tell the treating team immediately what medicine you use and when you last took it. An emergency does not allow the same preparation as a scheduled elective procedure. The team determines how to manage the situation based on the information available.
Do not delay necessary emergency care while trying to obtain advice from a subscription program. Bring the medication list or label if it is readily available, and tell the team about any uncertainty. If you do not know the exact dose, say so rather than guessing.
When can you restart after surgery?
Get the restart instructions from the clinical team. Ask whether the prescribing clinician needs to reassess the regimen, particularly after a longer interruption or if you have difficulty eating, drinking or tolerating medicines. The date of discharge by itself does not define a restart dose.
Our missed-dose and restart guide explains why routine late-dose directions do not cover every treatment gap. Tell the prescriber how many doses were actually missed and what the surgical team advised. Confirm whether the remaining medicine and prescription match the revised plan.
If the program bills automatically, also ask whether a pause affects refills and charges. Pausing medication on clinical advice and pausing a commercial subscription are separate steps. Our long-term program guide explains why flexibility belongs in a provider comparison.
How can you make the plan easier to follow?
Before the procedure, confirm four items in writing: the medicine plan, preparation instructions, the contact for questions and the restart process. Share the plan with anyone helping you prepare. Keep the most recent version with your medication list.
If the plan changes because of a dose increase or new symptoms, update both teams. The side-effect guide provides background, but new or concerning symptoms belong with the treating clinicians. Good coordination is more useful than searching for a single rule that promises to cover every drug, procedure and patient.
An example: a generic instruction sheet conflicts with your visit
Suppose a preoperative visit produces one medication plan, but an automated email later tells every patient to stop weekly injections. Call the procedural office with both instructions. State your exact product, last dose, recent changes and any symptoms, and ask the anesthesia team which instruction applies to you.
Do not interpret an automated message as a confirmed revision, and do not disregard it without clarification. Ask for the reconciled plan in writing, including the preparation and restart instructions. If another clinician manages your diabetes treatment, share the final version with that team too.
The same approach applies if your procedure is moved to a new date. A plan tied to the original appointment may need updating. Tell the office whether you have taken another dose since the first review, whether symptoms changed and whether the planned anesthesia is the same. The important outcome is a current coordinated decision, rather than a calendar calculation made without the clinical team.
Frequently asked questions
Must everyone stop GLP-1 medication before surgery?
No universal pause applies to everyone. Multisociety guidance supports continuation for many patients, with an individualized plan set by the anesthesia and prescribing teams.
What if I already took a dose before my procedure?
Tell the procedural and anesthesia teams the exact product and last-dose date. They decide how to proceed; do not assume automatic cancellation or that no change is needed.
References
- Novo Nordisk (2026). Wegovy prescribing information: pulmonary aspiration during general anesthesia or deep sedation. Novo Nordisk. https://www.novo-pi.com/wegovy.pdf
- Eli Lilly and Company (2026). Zepbound U.S. prescribing information: pulmonary aspiration during general anesthesia or deep sedation. Eli Lilly. https://pi.lilly.com/us/zepbound-uspi.pdf
- American Society of Anesthesiologists (2024). New multisociety GLP-1 clinical practice guidance. ASA. https://www.asahq.org/about-asa/newsroom/news-releases/2024/10/new-multi-society-glp-1-guidance
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Missed a GLP-1 Dose? Late Doses and Restarting Explained
Why missed-dose instructions differ for Wegovy, Ozempic and Zepbound, and what to tell your clinician after a longer treatment interruption.
ReadGLP-1 Lab Work: What to Ask Before a Telehealth Visit
Understand GLP-1 telehealth lab policies, recent-result transfers, extra fees and follow-up, without confusing fast enrollment with clinical suitability.
ReadCan You Use an HSA or FSA for GLP-1 Medication?
What to confirm before using HSA or FSA funds for GLP-1 medication, clinical visits and program fees, including receipts and reimbursement.
ReadGLP-1 Prior Authorization Denied: What to Check Next
A practical guide to GLP-1 insurance denials: identify the reason, gather the right documents and ask about internal appeals and external review.
ReadSwitching GLP-1 Providers: Records, Refills and Fees
How to change GLP-1 telehealth providers, transfer treatment records, compare the real bill and coordinate refills with your new prescriber.
ReadHow to Choose a GLP-1 Provider That Fits You
A friendly checklist for picking a GLP-1 telehealth provider — budget, formulary, speed, support and coverage — plus how our quiz matches you.
Read